Emerging Trends in Curcumin -Loaded SNEDDS for Brain Disorder from Nanoformulation to Patient-Centric Dosage Form

Classification of         Self-Emulsifying System      : SEDDS         , SMEDDS, SNEDDS:

• SEDDS (Self-Emulsifying Drug Delivery Systems):

SEDDS are isotropic mixtures of oils, surfactants, and sometimes co-solvents that spontaneously form coarse oil-in-water emulsions upon mild agitation in gastrointestinal fluids to enhance the solubility and absorption of poorly water-soluble drugs.They provide moderate bioavalability enhancement for BCS class 2 and 4 drugs.²

• SMEDDS (Self-Microemulsifying Drug Delivery Systems):

SMEDDS are lipid-based formulations composed of oils, surfactants, and co-surfactants that spontaneously produce transparent or slightly bluish microemulsions with droplet sizes typically below 100 nm when diluted in aqueous media,offering high thermodynamic stability and significant bioavlability enhancement .⁶

• SNEDDS (Self-Nanoemulsifying Drug Delivery Systems):

NEDDS are advanced lipid-based systems consisting of oils, surfactants, and co-surfactants that form fine nanoemulsions with droplet sizes generally below < 100 nm upon contact with gastrointestinal fluids, thereby improving drug solubility, bioavailability, and lymphatic transport.⁶

5. Comparison Between SEDDS ,SMEDDS,SNEDDS :

Self-emulsifying drug delivery systems (SEDDS) ,Self-microemulsifing drug delivery systems ( SMEDDS) ,and Self-nanoemulsifing drug delivery systems (SNEDDS) are lipid based formulation designed to enhanced the solubility ,permeability ,and bioavailability of poorly water soluble drug .

• Comparision Between SEDDS, SMEDDS, SNEDDS

5. Classification of SNEDDS :

SNEDDS may be systemically classified based on four principle criteria; (a) Physical state of the formulation, (b) droplet size generated upon aqueous dilution, (c) formulation strategy employed ,and (d) degree of functional modification. A Comprehensive overview of these categories ,along with their defining characteristics, key advantages ,and principle limitations.

Classification Based on Physical State :

The physical state of SNEDDS is one of the most fundamental classification criteria and directly influences formulation stability, manufacturing feasibility, and patient acceptability. Based on this criterion, SNEDDS are broadly categorized into liquid and solid systems.

A. Liquid SNEDDS

Liquid SNEDDS are homogeneous, clear mixtures of oils, surfactants, and co-surfactants.

5. Characteristics

• Droplet size typically <100 nm upon aqueous dilution.
• High      drug        solubilization  efficiency due to thermodynamically          driven nanoemulsification.
• Simple low-energy preparation without requirement for specialized equipment .¹

5. Limitations

• Potential leakage from soft gelatin capsules shells, particularly in the presence of hydrophilic co-solvent.⁶
• Limited physical stabilityy and chemical stability under ambient storage condition.

• Application
• Oral delivery of poorly soluble drugs such as curcumin ,cyclosporine A.
• Formulation of drug requiring rapid onse of action.

Fig 1: formation of liquid SNEDDS solution

B) Solid SNEDDS (S-SNEDDS)

Solid SNEDDS are produced by converting liquid SNEDDS into solid forms using suitable carriers.

Preparation techniques

• Adsorption onto porous materials ( e.g .Microcrystaline cellulose).
• Spray drying using aqueous or organic solvent system with suitable wall material.
• Melt granulation exploiting the thermoplastic properties of lipid excipients.

Advantages

• Improved stability compared with liquid counterparts.²¹
• Better handling and storage
• Enhanced patient compliance²⁰

Fig 2 : Liquid to solid conversion of SNEDDS

2. Classification on Based on Droplet Size After Dilution :
   1. SNEDDS

Form nanoemulsions with droplet size <100 nm Provide higher surface area and faster absorption

1. 2. SMEDDS (Self-Microemulsifying Drug Delivery Systems)

Produce microemulsions with droplet size of 100–250 nm Slightly lower bioavailability compared to SNEDDS

3. Classification Based on Formulation Strategy
   1. Supersaturable SNEDDS (S-SNEDDS)

Supersaturable SNEDDS incorporate precipitation inhibitors to maintain drug supersaturation following aqueous dilution.

Supersaturable SNEDDS incorporate precipitation inhibitors ,typically hydrophilic polymers such as hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP), or polyvinyl alcohol (PVA) is into the isotropic oil phase to maintain the drug in a thermodynamically supersaturated state following aqueous dilution. This strategy leverages the transient supersaturation achieved during nanoemulsification to enhance the thermodynamic driving force for drug absorption across the intestinal membrane.⁵

Advantages

3. • • Reduced surfactant concentration mitigation dose-related gastrointestinal toxicity .
     • Lower gastrointestinal irritation
     • Improved oral bioavailability without commensurate increase in surfcartant - medicated membrane perturbation.
4. Classification Based on Functional Modification
   1. Targeted SNEDDS

Targeted SNEDDS are surface-modified with ligands to enable site-specific delivery. Targeted SNEDDS are surface-engineered formulations in which the nanodroplet interface is decorated with specific ligands, antibodies, or receptor-recognizing moieties to confer active, site-directed drug delivery. This approach integrates the biopharmaceutical advantages of nanoemulsification with the pharmacological precision of receptor-mediated drug targeting, representing the most sophisticated category within the SNEDDS classification framework.²⁴

• Examples of ligands

1. Transferrin ,mediates receptor-mediated transcytosis across the blood–brain barrier via transferrin receptor (TfR) overexpressed on brain endothelial cells²⁵
2. Lactoferrintargets the lactoferrin receptor expressed on brain microvasculature, facilitating central nervous system drug delivery ,²⁵
3. Apolipoprotein-mimetic peptides , interact with low-density lipoprotein (LDL) receptors to enable receptor-mediated brain uptake²⁴

5. Application

• Enhanced drug delivery across the blood–brain barrier for treatment of glioblastoma and neurodegenerative disorders
• Tumor-targeted chemotherapy with reduced systemic toxicity
• Oral colon-specific drug delivery via pH- and receptor-sensitive surface modifications
• Theranostic applications combining diagnostic and therapeutic modalities within a single nanocarrier platform.

Excipients Used in SNEDDS Formulation

1. Oils

Oils play a crucial role in SNEDDS formulations as they act as solubilizing agents for lipophilic drugs. The presence of oil enhances the self-emulsification process and promotes lymphatic transport of the drug, leading to improved intestinal absorption and bioavailability. Medium- and long-chain triglycerides are commonly preferred due to their high drug solubilization capacity. Conventional cooking oils are generally avoided because of their limited emulsification efficiency and lower drug-loading capability. Hydrogenated vegetable oils and semi-synthetic lipid excipients are frequently employed as they provide better emulsification performance and formulation stability.⁶

2. Surfactants

Surfactants are essential components of SNEDDS and are primarily responsible for reducing interfacial tension between the oil and aqueous phases. Non-ionic surfactants are most commonly used due to their high hydrophilic–lipophilic balance (HLB), low toxicity, and better gastrointestinal tolerance. These surfactants facilitate rapid and spontaneous nanoemulsion formation upon dilution. Compared to ionic surfactants, non-ionic surfactants

exhibit improved safety profiles and enhanced permeability across the intestinal membrane, making them suitable for oral delivery systems.²

3. Co-surfactants

Co-surfactants are incorporated to further reduce interfacial tension and improve the flexibility of the interfacial film. They enhance the efficiency of self-nanoemulsification and assist in the formation of stable nano-sized droplets. Typically, short- or medium-chain alcohols and glycols are used as co-surfactants. Their inclusion enables higher surfactant loading and contributes to spontaneous emulsification, resulting in improved formulation performance and stability.⁴

Common Excipients Used in SNEDDS :

Role of Curcumin-SNEDDS in Alzheimer’s Disease

Curcumin-loaded SNEDDS have shown:

1. Enhanced inhibition of amyloid-β aggregation¹⁸
2. Improved cognitive performance in animal models²⁶
3. Reduction in neuroinflammatory markers²⁷
4. Increased brain bioavailability compared to free curcumin⁷

• Mechanism of Action of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS)

Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) enhance the oral and systemic delivery of poorly water-soluble drugs through a series of interconnected physicochemical and biological mechanisms. Upon exposure to aqueous gastrointestinal fluids under gentle agitation, SNEDDS spontaneously form fine oil-in-water nanoemulsions, thereby overcoming solubility- and permeability-related barriers that limit conventional drug delivery.1The led to an increase in drug solubility , bioavailability , as well as the permeability for the better therapeutic response.

SNEDDS are the isotropic mixture of oil ,surfactant and co-surfactant that improve drug delivery through a synergistic mechanism involving spontaneous nanoemulsification, enhanced solubilization, intestinal permeability modulation, lymphatic transport, and efflux inhibition. These combined actions significantly enhance oral bioavailability and brain targeting, positioning SNEDDS as a highly promising platform for the delivery of neurotherapeutics such as curcumin in Alzheimer’s disease.⁶

Fig 3: Self-Nanoemulsification drug delivery system

Preparation of SNEDDS : ( Liquid SNEDDS )

Selection of Excipients : The solubility of curcumin in various oil, surfactants and co-surfactant was determined using the screw capped vials These vial are subjected to mixing for 72 hr and after this centrifuge at 2500 rpm for 20 min .The supernatant was taken and diluted with methanol subjected to ulteaviolet (UV) and the best -performing excipients were selected for the formulation .⁷

Optimization of SNEDDS : The SNEDDS formulation was optimized based on pseudo-ternary phase diagrams, which helped determine the appropriate ratio of oil, surfactant ,and co-surfactant⁷

Formulation of SNEDDS : In the formulation of SNEDDS firstly add the Curcumin (API) and after add remaning excipient like a Oil ( Capryol 90 ) in which the curcumin are solubilize properly and then add surfactant (Tween 80) And add co-surfactant (TranscutolP).

Then selected oil ,surfactant ,and co-surfactant were mixed by vortexing for 5 min ,followed by gentle heating at 40 degree celcious to dissolve curcumin completely ,ensuring a homogeneous SNEDDS mixture

Application of Curcumin

Anticancer Activity : curcumin exhibits significant anticancer potential by inhibiting tumour cell proliferation ,angiogenesis ,and metastasis through modulating of multiple signaling pathways ,including NF-kB ,STAT3 , and MAPK .²⁸

Antidiabetic Activity: Curcumin improves glycemic control by reducing oxidative stress, suppressing protein kinase C activation, and enhancing insulin sensitivity, thereby showing potential in diabetes management.²⁸

Anti-arthritic Activity: Curcumin demonstrates strong anti-inflammatory and analgesic effects in rheumatoid arthritis by inhibiting cyclooxygenase enzymes and inflammatory mediators, with fewer adverse effects than conventional NSAIDs.²⁸

Anti-inflammatory Activity: Curcumin suppresses pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 by inhibiting NF-κB activation, contributing to its broad therapeutic applicability.²⁷

Wound Healing Activity: Curcumin accelerates wound repair by promoting collagen synthesis, re-epithelialization, granulation tissue formation, and growth factor expression.¹³ Anticoagulant Activity: Curcumin exhibits antithrombotic effect inhibiting platelet aggregation and modulating arachidonic acid-mediated coagulation pathways.28

Applications of Curcumin-Loaded SNEDDS in Alzheimer’s Disease

Enhanced Brain Bioavailability: Curcumin-loaded SNEDDS significantly improve oral bioavailability and facilitate enhanced brain delivery by increasing solubility, permeability, and systemic circulation time.⁷

Reduction of Amyloid-β Aggregation: SNEDDS-based curcumin formulations enhance the ability of curcumin to inhibit amyloid¹⁸-β plaque formation, a key pathological hallmark of Alzheimer’s disease.

Neuroprotective Effect: Curcumin SNEDDS provide neuroprotection by reducing oxidative stress, mitochondrial dysfunction, and neuronal apoptosis associated with neurodegeneration.²³

Anti-inflammatory Action in CNS: SNEDDS-mediated delivery enhances curcumin’s capacity to suppress neuroinflammation by downregulating microglial activation and pro-inflammatory cytokines in the brain.¹⁸

Improved Blood–Brain Barrier Permeation: Nano-sized droplets formed by SNEDDS facilitate improved penetration across the blood25–brain barrier, overcoming a major limitation of conventional curcumin formulations.

Improved Cognitive Function: Preclinical studies suggest that curcumin-loaded SNEDDS improve learning and memory performance by modulating cholinergic function and reducing neuronal damage.26

Reduced Dose-Related Toxicity: Enhanced delivery efficiency allows therapeutic effects at lower doses, thereby minimizing systemic side effects and improving patient safety.19

5. Evaluation of SNEDDS

Drug Content Uniformity:

Drug content analysis is performed to determine the amount of drug present in the SNEDDS formulation and to ensure uniform drug distribution. A predefined quantity of the formulation is diluted with a suitable solvent and analyzed using high-performance liquid chromatography (HPLC) or UV-visible spectrophotometry. This evaluation confirms formulation accuracy and dosage consistency.⁷

Droplet Size Analysis:

The mean droplet size and size distribution of SNEDDS are evaluated after dilution with distilled water. Dynamic light scattering (DLS) technique is commonly employed using a zeta sizer. Smaller droplet size indicates efficient self-nanoemulsification and improved drug absorption potential.6

Polydispersity Index (PDI):

PDI is measured to assess the uniformity of droplet size distribution within the nanoemulsion. Lower PDI values indicate homogeneous and stable SNEDDS formulations.6

Zeta Potential Measurement:

Zeta potential analysis is carried out to evaluate the surface charge and physical stability of the nanoemulsion. Adequate zeta potential values suggest resistance to droplet aggregation and improved formulation stability.⁶

Viscosity Measurement:

Viscosity of SNEDDS is measured using a Brookfield viscometer to assess flow behavior and suitability for oral or other routes of administration. Lower viscosity facilitates easy capsule filling and administration.⁷

Morphological Characterization:

The surface morphology and structural characteristics of SNEDDS droplets are examined using transmission electron microscopy (TEM) or scanning electron microscopy (SEM). These techniques provide visual confirmation of droplet size and spherical morphology.⁶

In vitro dissolution studies:

In-vitro drug release studies are performed using USP dissolution apparatus to evaluate the release profile of drug from SNEDDS. Suitable dissolution media are selected to simulate physiological conditions, and samples are analyzed at predetermined time intervals.⁷

Thermodynamic Stability Studies:

SNEDDS formulations are subjected to stress conditions such as centrifugation, heating–cooling cycles, and freeze–thaw cycles to assess physical stability and phase separation behavior.⁶

Centrifugation Test:

Centrifugation is performed to evaluate formulation stability by identifying phase separation or drug precipitation under accelerated conditions.⁶

Self-Emulsification Time:

The time required for spontaneous nanoemulsion formation upon dilution with aqueous media is measured to assess self-emulsification efficiency.¹

CONCLUSION

Self-nanoemulsifying drug delivery system (SNEDDS)have emerged as one of the most effective and promising approaches for controlled and sustained drug delivery .These systems are widely explored because of their ability to enhance drug solubility ,permeability ,and bio-availability ,especially for poorly water-soluble drug .SNEDDS have been successfully utilized for drug targeting through multiple routes ,including oral ,pulmonary ,vaginal, ophthalmic ,and nasal delivery .⁶

The high drug loading capacity of SNEDDS ,along with improved stability,makes them suitable for achieving maximum therapeutic efficacy without compromising formulation integrity .⁷

Moreover ,SNEDDS offer advantages such as improved dissolution rate ,enhanced absorption

,and consistent drug release ,which collectively contribute to better clinical outcomes.An additional benefit of this delivery system is its cost -effectiveness and flexibility ,as SNEDDS can be prepared using various formulation strategies without affecting drug stability

,Therefore ,SNEDDS represent a versatile and efficient drug delivery platform with strong potential for future pharmaceutical and clinical application .⁶

REFERENCES